Clinical Trial Update: Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer

View source ↗

Summary

This clinical trial update outlines a longitudinal study examining microbial and host signatures in patients with lung cancer undergoing immunotherapy, with the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: NYU Langone Health | Conditions: Lung Cancer | Status: RECRUITING